Product Information
TERBINAFINE HCL 250 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.1341 per EA under NDC 69097085902. Its NADAC has been published 516 times since Aug 10, 2016.
Strength
250 mg/1
Manufacturer
Cipla USA Inc.NDC
69097085902
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TERBINAFINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077533On Market Since
6/27/2016
Pharmacological Classes
Price Statistics
The NADAC for TERBINAFINE HCL 250 MG TABLET has been published 516 times since Aug 10, 2016, and over the history we have for it it has declined 13.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1341 per EA |
|---|---|
| All-time high | $0.1777 (Aug 11, 2021) |
| All-time low | $0.1158 (Nov 20, 2024) |
| 52-week high | $0.1513 |
| 52-week low | $0.1341 |
| Median price | $0.1541 |
| Average price | $0.1541 |
| Largest weekly change | -21.1% (Nov 20, 2024) |
| Weeks tracked | 516 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TERBINAFINE HCL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TERBINAFINE HCL 250 MG TABLET, manufactured by Cipla USA Inc., is $0.1341 per EA (NDC 69097085902), effective Jun 24, 2026.
How has the price of TERBINAFINE HCL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for TERBINAFINE HCL 250 MG TABLET has declined 13.5%. It has been tracked across 516 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for TERBINAFINE HCL 250 MG TABLET?
Since Aug 10, 2016, the NADAC for TERBINAFINE HCL 250 MG TABLET has ranged from a low of $0.1158 (Nov 20, 2024) to a high of $0.1777 (Aug 11, 2021), with a median of $0.1541 per EA.
Are there cheaper alternatives to TERBINAFINE HCL 250 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as TERBINAFINE HCL 250 MG TABLET, but none are currently priced below it.
Who manufactures TERBINAFINE HCL 250 MG TABLET?
TERBINAFINE HCL 250 MG TABLET (NDC 69097085902) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification